Facebook
Twitter
Telegram
Report an ErrorEmergent BioSolutions Cash Flow 2011-2024 | EBS
Annual Cash Flow Emergent BioSolutions
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-206 M | -34.1 M | 320 M | 537 M | 188 M | 41.8 M | 208 M | 54.6 M | 42.5 M | 112 M | 97 M | 39.6 M | 12.2 M |
Depreciation & Amortization |
125 M | 143 M | 124 M | 50.1 M | 49.5 M | 36.3 M | 32.2 M | 28 M | 23.7 M | 22.3 M | 17 M | 11.2 M | 9.36 M |
Accounts Payables |
112 M | 104 M | 129 M | 136 M | 94.8 M | 80.7 M | 41.8 M | 34.6 M | 46 M | 40.9 M | 27.5 M | 31.3 M | 40.5 M |
Accounts Receivables |
191 M | 159 M | 279 M | 231 M | 271 M | 262 M | 144 M | 138 M | 121 M | 58.8 M | 60.6 M | 96 M | 74.2 M |
Total Inventories |
329 M | 351 M | 344 M | 307 M | 222 M | 206 M | 143 M | 74 M | 76.9 M | 65.7 M | 14.6 M | 15.2 M | 14.7 M |
All numbers in USD currency
Quarterly Cash Flow Emergent BioSolutions
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | -37.3 M | - | - | - | 5.1 M | - | 291 M | 186 M | 57.8 M | - | 65.9 M | 69 M | 105 M | - | 208 M | 33.6 M | -1 M | - | 131 M | 95.7 M | 41.7 M | - | 67.3 M | 40.2 M | - | - | - | - | -65.9 M | - | 60.5 M | -18.4 M | -29.2 M | - | 88.3 M | 28.2 M | -4.63 M | - | 78.7 M | 32.2 M | 13.8 M | - | -24.7 M | -29.4 M | -22.7 M |
Depreciation & Amortization |
11.7 M | - | 20.3 M | - | 30.9 M | - | 14.5 M | 15.1 M | 28.7 M | - | 85.6 M | 56.8 M | 28.2 M | - | 82.8 M | 55.1 M | 26.6 M | - | 37.1 M | 24.7 M | 12.3 M | - | 29.9 M | 20.1 M | 10.2 M | - | 28.2 M | 17.8 M | 8.84 M | - | 25.9 M | 17.3 M | 8.53 M | - | 24.3 M | 15.3 M | 6.84 M | - | 13.5 M | 8.37 M | 4.16 M | - | 7.68 M | 4.91 M | 2.37 M | - | 6.93 M | 4.51 M | 2.24 M |
Accounts Payables |
113 M | 104 M | 101 M | - | 107 M | 129 M | 135 M | 152 M | 142 M | 136 M | 136 M | 136 M | 136 M | 94.8 M | 94.8 M | 94.8 M | 94.8 M | 80.7 M | 80.7 M | 80.7 M | 80.7 M | 41.8 M | 41.8 M | 41.8 M | 41.8 M | 34.6 M | 34.6 M | 34.6 M | 34.6 M | 38 M | 38 M | 46 M | 46 M | 40.9 M | 40.9 M | 40.9 M | 40.9 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 40.5 M | 40.5 M | 40.5 M | 40.5 M |
Accounts Receivables |
216 M | 159 M | 189 M | - | 182 M | 275 M | 255 M | 262 M | 184 M | 231 M | 231 M | 231 M | 231 M | 271 M | 271 M | 271 M | 271 M | 262 M | 262 M | 262 M | 262 M | 144 M | 144 M | 144 M | 144 M | 138 M | 138 M | 138 M | 138 M | 114 M | 114 M | 121 M | 121 M | 58.8 M | 58.8 M | 58.8 M | 58.8 M | 60.6 M | 60.6 M | 60.6 M | 60.6 M | 96 M | 96 M | 96 M | 96 M | 74.2 M | 74.2 M | 74.2 M | 74.2 M |
Total Inventories |
354 M | 351 M | 528 M | - | 401 M | 351 M | 365 M | 386 M | 406 M | 307 M | 307 M | 307 M | 307 M | 222 M | 222 M | 222 M | 222 M | 206 M | 206 M | 206 M | 206 M | 143 M | 143 M | 143 M | 143 M | 74 M | 74 M | 74 M | 74 M | 60.9 M | 60.9 M | 76.9 M | 76.9 M | 65.7 M | 65.7 M | 65.7 M | 65.7 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M |
All numbers in USD currency